FY27 Revenue Guidance Raised to ₹800+ Cr and Net Profit Guidance to ₹250+ Cr

Q2 FY27 total revenue expected to cross ₹200 Cr.

Wed 30 Sep 2026

Q2 FY27 Expected Total Revenue

expected to cross ₹200 Cr

FY27 Revenue Guidance

₹800+ Cr

FY27 Net Profit Guidance

₹250+ Cr

Warrant Conversion Approved

up to 30 lakh Baazar Style Retail warrants at ₹328.25 per share

South Africa Investment

USD 5 million follow-on investment in GII Healthcare Investment Limited

What the company said

Cupid released a press release on Q2 FY27 business updates, stating that Q2 FY27 Total Revenue is expected to cross ₹200 Cr.

Management revised its FY27 outlook upward

• FY27 Revenue Guidance: ₹800+ Cr
• FY27 Net Profit Guidance: ₹250+ Cr

The upward revision is attributed to Q2 momentum expected to continue through Q3 and Q4 FY27, improved visibility across institutional and private markets, continued expansion of the domestic FMCG business, progress towards imminent operationalization of the Palava facility, and sustained growth in the healthcare and personal care portfolio.

Q2 FY27 operational highlights

• Approved conversion of up to 30 lakh warrants of Baazar Style Retail Limited into an equivalent number of equity shares at ₹328.25 per share.
• Received in-principle approval for a manufacturing venture in South Africa, aimed at supporting local manufacturing and expansion across Africa and international markets.
• The South African initiative is to adopt an asset-light model with local partner support, targeting institutional procurement.
• Strengthened its healthcare partnership with GII Healthcare Investment Limited through an additional USD 5 million follow-on investment.
• Inclusion in BSE Group 'A', NIFTY Small Cap 250 and the FTSE Emerging Markets All Cap Index.

Looking ahead

• Scale domestic FMCG distribution across modern trade, general trade and pharmacy channels.
• Operationalise the Palava manufacturing facility to add capacity and flexibility.
• Expand the healthcare and personal care portfolio through new products and regulatory approvals.
• Build regional manufacturing platforms via the proposed South African venture.

Background

Established in 1993, Cupid manufactures male and female condoms, water-based lubricants, IVD kits and a growing FMCG portfolio. It exports to 125+ countries and says it is the first company in the world to receive WHO/UNFPA prequalification for both male and female condoms.

Note for readers

The revenue figure for Q2 FY27 is described as expected, and the FY27 numbers are guidance, not audited results. The company itself flags that forward-looking statements are subject to risks and uncertainties, and actual results may differ.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.